
    
      In this study, we will administer FluzoneÂ® High-Dose vaccine with a planned booster to
      patients with monoclonal gammopathies (stratified by requirement for therapy) irrespective of
      age. All patients will receive an initial vaccine followed by a booster vaccine 30 days (+/-
      7 days) later and will then be followed for outcomes until the end of flu season.
    
  